Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × Topotecan × 1 year × Clear all

Sponsor

Conditions

Small Cell Lung Carcinoma 13 Ovarian Neoplasms 12 Neuroblastoma 10 Fallopian Tube Neoplasms 8 Neoplasms 5 Uterine Cervical Neoplasms 4 Ganglioneuroblastoma 4 Carcinoma, Ovarian Epithelial 4 Brain Neoplasms 4 Retinoblastoma 3 Sarcoma, Ewing 2 Recurrence 2 Medulloblastoma 2 Leukemia, Myeloid, Acute 2 Glioma 2 Carcinoma, Non-Small-Cell Lung 2 Wilms Tumor 1 Thrombocythemia, Essential 1 SCLC, Extensive Stage 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Retinal Neoplasms 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Pleuropulmonary blastoma 1 Pediatric Brain Tumor 1 Osteosarcoma 1 Neoplasm Metastasis 1 Myelodysplastic-Myeloproliferative Diseases 1 Meningioma 1

Interventions

Cyclophosphamide 58 Rituximab 47 fludarabine 38 fludarabine phosphate 25 obinutuzumab 17 venetoclax 16 Lenalidomide 16 ibrutinib 15 Etoposide 14 Prednisone 13 pirtobrutinib 12 Whole-Body Irradiation 12 Mycophenolic Acid 11 Melphalan 11 Bendamustine Hydrochloride 11 Tacrolimus 10 Specimen Handling 10 Filgrastim 10 Doxorubicin 10 Biopsy 10 Vincristine 9 Magnetic Resonance Spectroscopy 9 Granulocyte Colony-Stimulating Factor 9 pembrolizumab 8 Stem Cell Transplantation 8 Peripheral Blood Stem Cell Transplantation 8 Nivolumab 8 Gemcitabine 8 Cytarabine 8 tocilizumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡